Institut Curie - Site Paris

This research site focuses on cancer studies across several neoplastic diseases, with trials aimed at improving treatment outcomes, testing new anti-cancer combinations, and refining supportive approaches for patients with advanced or hard-to-treat tumors.

• Studies in breast neoplasms are exploring new treatment strategies for advanced disease, including hormone receptor-positive and HER2-negative cancers.
• Research in non-small cell lung cancer is evaluating novel therapy combinations for KRAS G12C-mutant tumors that are either resected or unresectable.
• Trials in Ewing sarcoma are assessing ways to improve outcomes for newly diagnosed metastatic disease, including better use of chemotherapy and radiotherapy.

Overall, the clinical research program at Institut Curie is centered on finding more effective and better-tolerated treatments for aggressive cancers, while also examining how treatment selection can improve outcomes in metastatic disease and after surgery.